Abstract
Neuroblastomas from children presenting with tumors at various ages and different primary sites (abdominal, adrenals, pelvic, and thoracic) were studied. Analysis of the ganglioside patterns of 53 tumors indicated that patients who were either disease positive 2 yr following surgery or dead of disease, had significantly (p<0.005) less GT1b plus GD1b than tumors from patients that were disease free 2 yr post surgery. The presence of GD2 in 45 of the tumors correlates well with the suggestion that it can be used as a marker in neuroblastoma diagnosis. Children with thoracic neuroblastomas have a significantly better prognosis than children with tumors in other anatomic sites. Analysis of the ganglioside composition of these tumors only, indicated that they had a significantly higher (p<0.005) concentration of GT1b and GD1b and a significantly lower concentration (p<0.025) of monosialogangliosides than those patients who were dead of disease or had persistent disease. These results suggest that low levels of GT1b and GD1b correlate with a poor prognosis. The thoracic neuroblastomas may be comprised of more “differentiated” neuroblastoma cells (ganglioside patterns more similar to the CNS), and this may contribute to the fact that about 85% of children with thoracic neuroblastoma recover. To understand why the ganglioside pattern may serve as a prognostic indicator for neuroblastoma, it is necessary to know whether gangliosides have specific roles in neuronal differentiation. Our approach to this question is to compare the effect(s) of added ganglioside or the corresponding oligosaccharide on neuroblastoma cells. Results obtained suggest that the oligosaccharide from GM1 is able to enhance neuritogenesis by S20Y murine neuroblastoma cells to the same extent that GM1 does.
Similar content being viewed by others
References
Battistin L., Cesari A., Galligioni F., Marin G., Massarotti M., Paccagnella D., Pellegrini A., Testa G., and Tonin P. (1985) Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases.Euro. Neurol. 24, 343–351.
Baumann N., Harpin M. L., and Turpin J. C. (1981) Ganglioside content and pattern in tumor tissue of human neuroblastomas.Biomedicine 35, 214–217.
Blackburn C. C., Swank-Hill P., and Schnaar R. L. (1986) Gangliosides support neural retina cell adhesion.J. Biol. Chem. 261, 2873–2881.
Brady R. O., Fishman P. H., and Mora P. T. (1973) Membrane components and enzymes in virally transformed cells.Fed. Proc. 32, 102–108.
Buck C. A., Glick M. C., and Warren L. (1971) Effect of growth on the glycoproteins from the surface of control and Rous Sarcoma virus transformed hamster cells.Biochemistry 10, 2176–2180.
Burger M. M. (1970) Proteolytic enzymes initiating cell division and escape from contact inhibition of growth.Nature (London)227, 170, 171.
Byrne M. C., Ledeen R. W., Roisen F. J., Yorke G., and Sclafani J. R. (1983) Ganglioside-induced neuritogenesis: verification that gangliosides are the active agents and comparison of molecular species.J. Neurochem. 41, 1214–1222.
Carine K. and Schengrund C.-L. (1984) Effects of exogenous GM1 and GD1a on S20Y neuroblastoma cells.J. Neurosci. Res. 12, 59–69.
Ciesielski-Treska J., Robert J., Rebel G., and Mandel P. (1977) Gangliosides of active and inactive neuroblastoma clones.Differentiation 8, 31–37.
Dawson G., Kemp S. F., Stoolmiller A. C., and Dorfman A. (1971) Biosynthesis of glycosphingolipids by mouse neuroblastoma (NB41A), rat glia (RGC-6) and human glia (CHB-4) in cell culture.Biochem Biophys. Res. Commun. 44, 687–694.
Dawson G. and Stoolmiller A. C. (1976) Comparison of the ganglioside composition of established neuroblastoma cell strains grownin vivo and in tissue culture.J. Neurochem. 26, 225, 226.
Filler R. M., Traggis D. G., Jaffe N., and Vawter G. F. (1972) Favorable outlook for children with mediastinal neuroblastoma.J. Pediatr. Surg. 7, 136–143.
Ghidoni R., Sonnino S., Masserini M., Orlando P., and Tettamanti G. (1981) Specific tritium labeling of gangliosides at the 3-position of sphingosines.J. Lipid Res. 22, 1286–1295.
Hanai N., Nores G., Torres-Mendez C.-R., and Hakomori, S.-I. (1987) Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note.Biochem. Biophys. Res. Commun. 147, 127–134.
Horowitz S. H. (1986) Ganglioside therapy in diabetic neuropathy.Muscle and Nerve,9, 531–536.
Jaffe N. (1982) Biologic vagaries in neuroblastoma,Neuroblastoma Clinical and Biological Manifestations (Pochedly C., ed.), pp. 293–309, Elsevier, New York, NY.
Kemp R. B. (1971) Studies on the role of cell surface sialic acids in intercellular adhesion.Folia Histochem. Cytochem. 9, 25–30.
Kemshead J. T., Health L., Gibson F. M., Katz F., Richmond F., Treleaven J., and Ugelstad J. (1986) Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.Br. J. Cancer 54, 771–778.
Ladisch S. and Wu Z.-L. (1985) Detection of a tumor-associated ganglioside in plasma of patients with neuroblastoma.Lancet 1, 136–138.
Ladisch S., Wu Z.-L., Feig S., Ulsh L., Schwartz E., Floutsis G., Wiley F., Lenarsky C., and Seeger R. (1987) Shedding of GD2 ganglioside by human neuroblastoma.Int. J. Cancer 39, 73–76.
Miljkovic M. and Schengrund C.-L. (1986) Oxidative degradation of glycosphin-golipids revisited: a simple preparation of oligosaccharides from glycosphingolipids.Carbohydr. Res. 155, 175–181.
Miraldi F. D., Nelson A. D., Kraly C., Ellery S., Landmeier B., Coccia P. F., Strandjord S. E., and Cheung N.-K. V. (1986) Diagnostic imaging of human neuroblastoma with radiolabeled antibody.Radiology 161, 413–418.
Nakajima J., Tsuji S., and Nagai Y. (1986) Bioactive gangliosides: analysis of functional structures of the tetrasialoganglioside GQ1b which promotes neurite outgrowth.Biochim. Biophys. Acta 876, 65–71.
Purpura D. P. and Baker H. J. (1977) Neurite induction in mature cortical neurones in feline GM1-ganglioside storage disease.Nature (London)266, 553–554.
Roisen F. J., Bartfeld H., Nagele R. and Yorke G. (1981) Ganglioside stimulation of axonal sproutingin vitro.Science 214, 5477, 5478.
Sabel B. A., Slavin M. D., and Stein D. G. (1984) GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage.Science 225, 340–342.
Saito M., Yu R. K., and Cheung N.-K. V. (1985) Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.Biochem. Biophys. Res. Commun. 127, 1–7.
Sakiyama H. and Robbins P. W. (1973) Glycolipid synthesis and tumorigenicity of clones isolated from the Nil 2 line of hamster embryo fibroblasts.Fed. Proc. 32, 86–90.
Schengrund C.-L. and Nelson J. T. (1976) Sialidase activity in mouse neuroblastoma cell lines.Neurochem. Res. 1, 181–190.
Schengrund C.-L. and Prouty C. P. (1988) The oligosaccharide protion of GM1 enhances process formation by S20Y neuroblastoma cells.J. Neurochem. 51, 277–282.
Schengrund C.-L. and Repman M. A. (1977) Cell culture of sixteen-day-old rat embryo cerebra and associated changes in ganglioside pattern.J. Neurochem. 29, 923–927.
Schengrund C.-L., Repman M. A. and Schochat S. J. (1985) Ganglioside composition of human neuroblastomas, correlation with prognosis. A pediatric oncology group study.Cancer 56, 2640–2646.
Schulz G., Cheresh D. A., Varki N. M., Yu A., Staffileno L. K., and Reisfeld R. A. (1984) Detection of ganglioside GD2 in tumor tissue and sera of neuroblastoma patients.Cancer Res. 44, 5914–5920.
Shochat S. J., Abt A. B., and Schengrund C.-L. (1977) VCN-releasable sialic acid and gangliosides in human neuroblastoma.J. Pediatr. Surg. 12, 413–418.
Shochat S. J., Corbelletta N. L., Repman M. A., and Schengrund C.-L. (1987) A biochemical analysis of thoracic neuroblastomas: a pediatric oncology group study.J. Pediatr. Surg. 22, 660–664.
Svennerholm L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.Biochim. Biophys. Acta. 24, 604–611.
Svennerholm L. (1963) Chromatographic separation of human brain gangliosides.J. Neurochem 10, 613–623.
Willinger M. (1981) The expression of GM1 ganglioside during neuronal differentiation,Gangliosides in Neurological and Neuromuscular Function, Development, and Repair (Rapport M. M. and Gorio A., eds.), pp. 17–27, Raven Press, New York, NY.
Yates A. J., Thompson D. K., Boesel C. P., Albrightson C., and Hart R. W. (1979) Lipid composition of human neural tumors.J. Lipid Res. 20, 428–436.
Yavin E. and Yavin Z. (1979) Ganglioside profiles during neural tissue development.Dev. Neurosci. 2, 25–37.
Yogeeswaran G., Murray R. K., Pearson M. L., Sanwal B. D., McMorris F. A., and Ruddle F. H. (1973) Glycosphingolipids of clonal lines of mouse neuroblastoma and neuroblastoma x L cell hybrids.J. Biol. Chem. 248, 1231–1239.
Yogeeswaran G., Sheinin R., Wherrett J. R., and Murray R. K. (1972) Studies on the glycosphingolipids of normal and virally transformed 3T3 mouse fibroblasts.J. Biol. Chem. 247, 5146–5158.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schengrund, CL., Shochat, S.J. Gangliosides in Neuroblastomas. Neurochemical Pathology 8, 189–202 (1988). https://doi.org/10.1007/BF03160146
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03160146